Trial document




drksid header

  DRKS00021289

Trial Description

start of 1:1-Block title

Title

Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Study to estimate the number of unreported SARS-CoV-2 (COVID-19) in public sector persons in Bremen.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Epidemiological study with the aim of identifying the dark number of seropositive persons (SARS-CoV-2 serology) within the Bremen public service.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

No

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00021289
  •   2020/04/14
  •   [---]*
  •   yes
  •   Approved
  •   713, Ethik-Kommission der Ärztekammer Bremen
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   U07.1 -  Emergency use of U07.1
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   One-time survey and blood collection of about 100 public servants in Bremen.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Epidemiological study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Prevention
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The aim of the study is to identify the number of seropositive persons (SARS-CoV-2 serology) in public sector persons. For this, 100 study participants (laboratory results and questionnaires) are needed for this purpose.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

The aim of the study is to identify the number of seropositive persons (SARS-CoV-2 serology) in public sector persons. Recruitment phase is planned up to (and including) May 2020.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • other 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2020/03/31
  •   100
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   16   Years
  •   67   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

public sector workers

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

currently acute respiratory disease

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Performa Nord Zentrum für Gesunde Arbeit Arbeitsmedizinischer Dienst
    • Mr.  Dr.  Jan  Neumann 
    • Schillerstraße 1
    • 28195  Bremen
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Performa Nord Zentrum für Gesunde Arbeit Arbeitsmedizinischer Dienst
    • Mr.  Dr.  Jan  Neumann 
    • Schillerstraße 1
    • 28195  Bremen
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Performa Nord Zentrum für Gesunde Arbeit Arbeitsmedizinischer Dienst
    • Mr.  Dr.  Jan  Neumann 
    • Schillerstraße 1
    • 28195  Bremen
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Performa Nord Zentrum für Gesunde Arbeit Arbeitsmedizinischer Dienst
    • Mr.  Dr.  Jan  Neumann 
    • Schillerstraße 1
    • 28195  Bremen
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2020/05/16
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.